Abstract
BackgroundAlthough more modern methods are available, quantitative PCR (qPCR) is reproducible, sensitive and specific with instruments and expertise readily available in many laboratories. As such, the use of qPCR in Cryptosporidium research is well established and still widely used by researchers globally. This method depends upon the generation of standards at different concentrations to generate standard curves subsequently used for the quantification of DNA.MethodsWe assessed four types of DNA template used to generate standard curves in drug screening studies involving Cryptosporidium spp.: (i) serially diluted Cryptosporidium parvum oocysts (106–1); (ii) diluted template DNA from pure oocysts (×10–×106 dilution of 106 oocyst DNA template); (iii) oocysts incubated in human ileocecal adenocarcinoma (HCT-8) cells (105–1 and 5 × 104–50); and (iv) diluted DNA template (5 × 104) from cell culture incubated parasites (×10–×1000).ResultsSerial dilutions of both cell culture and pure oocyst suspension DNA template yielded better linearity than cell culture derived standards, with dilutions of 106 oocysts exhibiting similar quantification cycle (Cq) values to those obtained from DNA template dilutions of 106 oocysts. In contrast, cell culture incubated oocysts demonstrated significantly higher DNA content than equivalent freely suspended oocysts and diluted DNA template from both cell culture derived and freely suspended oocysts across numerous concentrations.ConclusionsFor many studies involving Cryptosporidium, only relative DNA content is required and as such, the superior linearity afforded by freely suspended oocysts and diluted DNA template (from either cell culture derived standards or freely suspended oocysts) will allow for more accurate relative quantification in each assay. Parasite division in the cell culture standards likely explains the higher DNA content found. These standards, therefore, have the potential to more accurately reflect DNA content in cell culture assays, and despite more modern methods available for absolute quantification, i.e. droplet digital PCR (ddPCR), the ubiquity of qPCR for the foreseeable future encourages further investigation into the reduced linearity observed in these standards such as varying oocyst seeding density, non-linear growth rates and assay efficiency.
Highlights
More modern methods are available, quantitative polymerase chain reaction (PCR) is reproducible, sensitive and specific with instruments and expertise readily available in many laboratories
This study clearly demonstrates important differences in the results generated between cell-culture incubated oocysts, pure oocyst dilutions and their respective DNA template equivalents when used as standards for quantitative PCR (qPCR)
The potential loss of cell viability at the highest seeding densities could suggest the use of inoculates < 105 would be appropriate for cell culture assays
Summary
More modern methods are available, quantitative PCR (qPCR) is reproducible, sensitive and specific with instruments and expertise readily available in many laboratories. The use of qPCR in Cryptosporidium research is well established and still widely used by researchers globally. This method depends upon the generation of standards at different concentrations to generate standard curves subsequently used for the quantification of DNA. Protozoan parasites of the genus Cryptosporidium are a significant cause of enteric disease in humans and animals globally [1]. Treatment options are insufficient and vary between countries, with only one drug approved for use, nitazoxanide (Alinia®, Romark L.C., Tampa, USA) in humans and halofuginone lactate (Halocur®, Intervet Productions S.A., Igovilles, France; Halagon®, Divasa-Farmavic, S.A., Barcelona, Spain; Kriptazen®, Virbac, Carros, France), and paromomycin (Parofor®, Huvepharma NV, Sofia, Bulgaria) in calves, respectively. None of the drugs are able to completely prevent or cure the disease [1, 7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.